| Literature DB >> 20626848 |
Irene P Jongerden1, Anne Marie G de Smet, Jan A Kluytmans, Leo F te Velde, Paul J Dennesen, Ronald M Wesselink, Martijn P Bouw, Rob Spanjersberg, Diana Bogaers-Hofman, Nardo J van der Meer, Jaap W de Vries, Karin Kaasjager, Mat van Iterson, Georg H Kluge, Tjip S van der Werf, Hubertus I Harinck, Alexander J Bindels, Peter Pickkers, Marc J Bonten.
Abstract
INTRODUCTION: Use of selective decontamination of the digestive tract (SDD) and selective oropharyngeal decontamination (SOD) in intensive care patients has been controversial for years. Through regular questionnaires we determined expectations concerning SDD (effectiveness) and experience with SDD and SOD (workload and patient friendliness), as perceived by nurses and physicians.Entities:
Mesh:
Year: 2010 PMID: 20626848 PMCID: PMC2945100 DOI: 10.1186/cc9180
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Study protocol
| Study period | Oral hygiene | Oral paste† | Suspension¥ | Cefotaxim* |
|---|---|---|---|---|
| SDD | + | + | + | + |
| SOD | + | + | ||
| Standard care | + |
SDD, selective decontamination of the digestive tract; SOD, selective oropharyngeal decontamination.
+ applied four times a day.
† Oral paste consists of polymyxin, tobramycin, amphotericin B and is applied in the oropharynx.
¥ Suspension consists of polymyxin, tobramycin, amphotericin B and is applied in the gastrointestinal tract through a feeding tube.
*Cefotaxim applied intravenous during first four days.
Response and expectations of the effect of SDD per study period
| Nurses | Physicians | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1st | 2nd | 3rd | 1st | 2nd | 3rd | 1st | 2nd | 3rd | ||||
| Response - no. (%) | 372 (74) | 339 (73) | 313 (65) | 85 (89) | 89 (82) | 79 (77) | ||||||
| Prior experience SDD - % | 53 | 74 | 87 | 68 | 85 | 90 | ||||||
| Effect SDD - no. (%) | ||||||||||||
| No effect | 101 (33) | 80 (26) | 63 (22) | 0.017 | 12 (14) | 12 (14) | 3 (4) | 0.065 | 113 (29) | 92 (23) | 66 (18) | 0.004 |
| Decrease pneumonia | 135 (43) | 151 (49) | 165 (58) | 0.002 | 64 (75) | 71 (80) | 65 (84) | 0.354 | 199 (50) | 222 (56) | 230 (68) | 0.001 |
| Increase resistance | 68 (22) | 68 (22) | 48 (17) | 0.209 | 14 (17) | 19 (21) | 21 (27) | 0.247 | 82 (21) | 87 (22) | 69 (19) | 0.624 |
| Decrease resistance | 24 (8) | 21 (7) | 25 (9) | 0.672 | 11 (13) | 13 (15) | 14 (18) | 0.640 | 35 (9) | 34 (9) | 39 (11) | 0.524 |
| Increase survival* | 81 (26) | 83 (27) | 97 (34) | 0.062 | 36 (42) | 45 (51) | 47 (61) | 0.059 | ||||
| Other | 21 (7) | 35 (11) | 25 (9) | 0.129 | 9 (11) | 11 (12) | 13 (17) | 0.478 | 30 (8) | 46 (12) | 38 (11) | 0.145 |
| Median PRRM (IQR) | 3.0 (0-25) | 12.9 (0-25) | 16.7 (0-28.5) | 0.113 | ||||||||
IQR, interquartile range; PRRM, presumed relative reduction in mortality; SDD, selective decontamination of the digestive tract.
* Increase survival physicians based upon calculation PRRM.
significance based upon chi-squared test (effect) or Kruskal-Wallis test (median PRRM).
Free-text responses on additional effect of SDD - no
| Nurses | Physicians | |
|---|---|---|
| No idea | 82 | 1 |
| Better oral hygiene | 39 | - |
| Increase colonization Enterococci/other bacteriae | 3 | 6 |
| Decrease other infections (besides VAP) | 15 | 10 |
| Other infection pattern | - | 2 |
| More frequent growth of yeasts | 13 | 3 |
| Less frequent growth of yeasts | 2 | - |
| Decrease length of stay | 6 | 9 |
| Increase length of stay | - | 1 |
| Better bacterial monitoring/antibiotics regimen | 2 | 3 |
| Increase diarrhea/change intestinal flora | 3 | - |
| Decrease multi organ failure | 1 | - |
| Decrease complications | - | 1 |
| Increase complications(wrong application) | - | 1 |
| Decrease morbidity | - | 1 |
| Decrease mechanical ventilation | - | 2 |
SDD, selective decontamination of the digestive tract; VAP, ventilator-associated pneumonia.
Application of study protocol by nurses per intervention period
| SDD | SOD | Standard care | ||
|---|---|---|---|---|
| Extra time in minutes‡ - median (IQR) | 5.0 (2-5) | 3.0 (0-5) | 3.0 (0-5) | 0.000 |
| Problems‡ - % of times reported | 79 | 74 | ||
| - Patient disliked taste of oral paste - % | 48 | 44 | 0.336 | |
| - Patient disliked suspension - % | 22 | -- | -- | |
| - Patient was nauseous - % | 17 | 9 | 0.003 | |
| - Patient found oral care annoying - % | 54 | 58 | 0.318 | |
| - Patient did not cooperate with oral care - % | 37 | 34 | 0.377 | |
| Change in application Orabase‡ - % | 31 | 29 | 0.305 | |
| - once not given - % | 14 | 12 | ||
| - given at another time - % | 2 | 4 | ||
| - discontinued - % | 7 | 8 | ||
| - other - % | 8 | 5 | ||
IQR, interquartile range; SDD, selective decontamination of the digestive tract; SOD, selective oropharyngeal decontamination.
‡ Extra time, problems and change in application as reported by nurses.
significance based upon chi-squared (problems, changes) or Kruskal-Wallis test (median extra time).
Median grades (interquartile ranges) for the three intervention periods
| N | SDD | SOD | Standard care | ||
|---|---|---|---|---|---|
| median (IQR) | median (IQR) | median (IQR) | |||
| Workloada | 207 | 5.0 (4.0-7.0) | 4.0 (3.0-6.0) | 2.0 (1.0-4.0) | 0.000 |
| Pt friendlinessb | 197 | 4.0 (2.0-5.0) | 4.0 (3.0-6.0) | 7.0 (3.0-9.0) | 0.000 |
| Workloada | 30 | 5.5 (3.8-7.0) | 5.0 (3.0-6.0) | 2.5 (2.0-4.0) | 0.000 |
| Pt friendlinessb | 27 | 6.0 (4.0-7.0) | 6.0 (4.0-6.0) | 8.0 (6.0-9.0) | 0.003 |
IQR, interquartile range; N, number of responses; pt, patient; SDD, selective decontamination of the digestive tract; SOD, selective oropharyngeal decontamination.
significance based upon Friedman test.
a Workload measured on a scale from 1 (low) to 10 (high).
b Patient friendliness measured on a scale from 1 (poor) to 10 (excellent).